BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 4963979)

  • 1. Weight reduction with phenmetrazine: a double-blind study.
    Hadler AJ
    Curr Ther Res Clin Exp; 1967 Sep; 9(9):462-7. PubMed ID: 4963979
    [No Abstract]   [Full Text] [Related]  

  • 2. Phenmetrazine vs. phenmetrazine with amobarbital for weight reduction: a double-blind study.
    Hadler AJ
    Curr Ther Res Clin Exp; 1969 Dec; 11(12):750-4. PubMed ID: 4984039
    [No Abstract]   [Full Text] [Related]  

  • 3. Weight reduction with phenmetrazine and chlorphentermine a double-blind study.
    Hadler AJ
    Curr Ther Res Clin Exp; 1967 Nov; 9(11):563-9. PubMed ID: 4965505
    [No Abstract]   [Full Text] [Related]  

  • 4. Weight reduction with chlorphenetermine and phenmetrazine in obese psychiatric patients during chlorpromazine therapy.
    Sletten IW; Ognjanov V; Menendez S; Sundland D; el-Toumi A
    Curr Ther Res Clin Exp; 1967 Nov; 9(11):570-5. PubMed ID: 4965506
    [No Abstract]   [Full Text] [Related]  

  • 5. Obesity: phenmetrazine effect without dietary restriction.
    Huston JR
    Ohio State Med J; 1966 Aug; 62(8):805-7. PubMed ID: 5329662
    [No Abstract]   [Full Text] [Related]  

  • 6. The effectiveness of phenmetrazine in obesity.
    Jenner EB
    N Z Med J; 1968 Jan; 67(426):147-9. PubMed ID: 4867885
    [No Abstract]   [Full Text] [Related]  

  • 7. Chlorphentermine and phenmetrazine compared: weight reduction, side effects and psychological change.
    Sletten IW; Sundland D; Pichardo J; Viamontes G
    Mo Med; 1967 Nov; 64(11):927-9. PubMed ID: 6056101
    [No Abstract]   [Full Text] [Related]  

  • 8. ["Free" and "bound" plasmatic insulin activity in obese patients treated with phenmetrazine].
    Dascălu R; Gozariu L; Florescu O; Rosan L; Vişinescu I
    Stud Cercet Endocrinol; 1965; 16(3):279-84. PubMed ID: 5850641
    [No Abstract]   [Full Text] [Related]  

  • 9. [Controlled clinical trials of a new appetite-inhibiting drug].
    Bani G; Barba C; Ricci G
    Clin Ter; 1968 Oct; 47(2):161-74. PubMed ID: 5702726
    [No Abstract]   [Full Text] [Related]  

  • 10. [Changes in blood lipids in patients treated with reducing diets. Use of delayed-action phenmetrazine].
    Castillo Rosell S; Serrano Maass PA; Bisteni A; Calcáneo F
    Arch Inst Cardiol Mex; 1966; 36(4):454-63. PubMed ID: 5917992
    [No Abstract]   [Full Text] [Related]  

  • 11. Weight control in obese diabetics. A comparative trial of Filon and phenmetrazine.
    Buckle RM; Silverstone JT
    Br J Clin Pract; 1966 Jul; 20(7):363-5. PubMed ID: 5940969
    [No Abstract]   [Full Text] [Related]  

  • 12. Obesity-depression: clinical evaluation with a new anorexigenic agent.
    Kornhaber A
    Psychosomatics; 1973; 14(3):162-7. PubMed ID: 4604838
    [No Abstract]   [Full Text] [Related]  

  • 13. [Weight loss by treatment with Fugoa depot. Results of a double blind study].
    Muth H; Issmeier G
    Ther Ggw; 1980 Oct; 119(10):1173-83. PubMed ID: 7008236
    [No Abstract]   [Full Text] [Related]  

  • 14. [Ephedrine in the treatment of obesity. A double-blind cross-over trial of the effect of Elsinore tablets].
    Lumholtz IB; Thorsteinsson B; Wamberg T; Lehnschau A; Hansen G; Spellerberg S; Lund B
    Ugeskr Laeger; 1980 Jun; 142(23):1487-90. PubMed ID: 6996251
    [No Abstract]   [Full Text] [Related]  

  • 15. A double-blind clinical evaluation of the safety and efficacy of phentermine hydrochloride (Fastin) in the treatment of exogenous obesity.
    Langlois KJ; Forbes JA; Bell GW; Grant GF
    Curr Ther Res Clin Exp; 1974 Apr; 16(4):289-96. PubMed ID: 4208343
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of Cafilon in the treatment of obesity (author's transl)].
    Honzák R; Rath R; Vondra K
    Cesk Gastroenterol Vyz; 1976 Apr; 30(3):155-61. PubMed ID: 1277334
    [No Abstract]   [Full Text] [Related]  

  • 17. A clinical trial of an appetite suppressant in refractory obesity (with a note on assessment of weight loss).
    Peaston MJ
    Br J Clin Pract; 1965 Sep; 19(9):503-6. PubMed ID: 5318222
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of Elsinore tablets in the treatment of obesity. A controlled clinical trial].
    Malchow-Møller A; Larsen S; Hey H; Stokholm KH; Juhl E; Quaade F
    Ugeskr Laeger; 1980 Jun; 142(23):1496-9. PubMed ID: 6996253
    [No Abstract]   [Full Text] [Related]  

  • 19. Pondex, a hydantoin derivative, in the management of obesity.
    Krese A; Kiselá J
    Ther Hung; 1968; 16(2):89-90. PubMed ID: 5666420
    [No Abstract]   [Full Text] [Related]  

  • 20. Reduced-dosage sustained-action phenmetrazine in obesity.
    Hadler AJ
    Curr Ther Res Clin Exp; 1968 Jun; 10(6):255-9. PubMed ID: 4969829
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.